e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Outcomes and new treatment strategies in pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Supraventricular Arrhythmias in Pulmonary Arterial Hypertension
V. Mercurio (Baltimore, United States of America)
Source:
International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Session:
Outcomes and new treatment strategies in pulmonary hypertension
Session type:
Poster Discussion
Number:
3523
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Mercurio (Baltimore, United States of America). Supraventricular Arrhythmias in Pulmonary Arterial Hypertension. 3523
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Pulmonary Hypertension
Source: Eur Respir Rev 2009; 18: 193-194
Year: 2009
Pulmonary Hypertension
Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development
Year: 2013
Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Contribution of BMP9 to Pulmonary Arterial Hypertension
Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension
Year: 2017
Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Role of CHK1 in Pulmonary Arterial Hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
Chronic Thromboembolic Pulmonary Hypertension related to ICD
Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension
Year: 2018
Interventional Treatment in Chronic Thromboembolic Pulmonary Hypertension with Microvasculopathy
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020
Nebivolol and pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Long Non-coding RNA H19 in Right Ventricular Failure associated with Pulmonary Arterial Hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
A Minimal Clinically Important Difference for CAMPHOR in Idiopathic Pulmonary Arterial Hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Cerebral tissue oxygenation in arterial and thromboembolic pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept